NORDITROPIN Side Effects

6517763-1 | Craniopharyngioma
on Dec 16, 2009 Male patient from UNITED STATES , weighting 319.4 lb, was diagnosed with growth hormone deficiency, hypopituitarism, hyperinsulinaemia and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: craniopharyngioma. Norditropin dosage: Unk. During the same period patient was treated with SYNTHROID (200 Mg, Qd) (View Synthroid Review and Synthroid Label ), CORTEF /00028601/ (15 Mg Am, 10 Mg Pm) (View Cortef /00028601/ Review and Cortef /00028601/ Label ), DESMOPRESSIN (0.2 Mg, Qd) (View Desmopressin Review and Desmopressin Label ), ANDROGEL (7.5 Mg, Qd) (View Androgel Review and Androgel Label ), METFORMIN HCL (1000 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ).

6505407-4 | Neurilemmoma
Patient was taking Norditropin (View Usage). Patient had the following side effects: neurilemmoma on Dec 11, 2009 from SERBIA Additional patient health information: Female patient , child 11 years of age, weighting 68.34 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: .95 Mg, Qd. Patient was hospitalized.

6505405-0 | Enchondroma
Adverse event was reported on Dec 11, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: .2 Mg, Qd) was diagnosed with hypopituitarism and. Location: GERMANY , weighting 216.3 lb, After Norditropin was administered, patient had the following side effects: enchondroma. During the same period patient was treated with NORPROLAC (75 Ug, Qd) (View Norprolac Review and Norprolac Label ), HYDROCORTISON /00028601/ (15 Mg, Qd) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ), MOXONIDIN (.4 Mg, Qd) (View Moxonidin Review and Moxonidin Label ), ACCUZIDE (20 Mg, Qd) (View Accuzide Review and Accuzide Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ).

6456838-2 | Convulsion
on Nov 17, 2009 Male patient from NETHERLANDS , child 10 years of age, was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Norditropin dosage: 2 Mg, Qd.


6456588-2 | Convulsion, Hypoglycaemia, Viral Infection
on Nov 16, 2009 Male patient from NEW ZEALAND , child 3 years of age, was treated with Norditropin (View Usage). Patient had the following side effects: convulsion, hypoglycaemia, viral infection (What is viral infection?). Norditropin dosage: 0.5 Mg, Qd. Patient was hospitalized.

6454797-X | Alpha Haemolytic Streptococcal Infection, Auricular Swelling, Haemophilus Infection, Hair Follicle Tumour Benign, Nasopharyngitis, Neisseria Infection, Viral Infection
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: alpha haemolytic streptococcal infection, auricular swelling, haemophilus infection, hair follicle tumour benign, nasopharyngitis, neisseria infection, viral infection (What is viral infection?) on Oct 28, 2009 from SLOVAKIA (Slovak Republic) Additional patient health information: Female patient , child 6 years of age, weighting 34.39 lb, was diagnosed with growth hormone deficiency, small for dates baby and. Norditropin dosage: 0.5 Mg, Qd; 0.5 Mg, Qd.

6432152-6 | Pancreatitis
Adverse event was reported on Oct 29, 2009 by a Female patient taking Norditropin (View Usage) (Dosage: 0,033 Mg/kg/day 6 Weekly Doses) was diagnosed with hypopituitarism and. Location: ITALY , 13 years of age, weighting 151.7 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. Patient was hospitalized.

6426587-5 | Skin Striae
on Oct 26, 2009 Male patient from GERMANY , weighting 102.3 lb, was diagnosed with small for dates baby and was treated with Norditropin (View Usage). Patient had the following side effects: skin striae. Norditropin dosage: Unk.

6410702-3 | Joint Stiffness
on Oct 13, 2009 Male patient from GERMANY , weighting 34.83 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: joint stiffness. Norditropin dosage: .5 Mg, Qd. Patient was hospitalized.

6410521-8 | Breast Mass, Condition Aggravated, Diabetic Retinopathy
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: breast mass, condition aggravated, diabetic retinopathy on Aug 10, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 41 years of age, was diagnosed with hypopituitarism and. Norditropin dosage: .6 Unk, Qd. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6407093-0 | Cough, Dysphonia
Adverse event was reported on Oct 09, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: .3 Mg, Qd) was diagnosed with growth hormone deficiency, small for dates baby and. Location: GERMANY , weighting 30.20 lb, Patient had the following side effects: cough, dysphonia.

6393161-9 | Vasculitis
on Oct 01, 2009 Female patient from BELGIUM , child 12 years of age, weighting 67.90 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: vasculitis (What is vasculitis?). Norditropin dosage: 1.5 Mg, Qd.

6387735-9 | Colorectal Cancer
on Sep 24, 2009 Male patient from SWEDEN , 18 years of age, weighting 123.5 lb, was diagnosed with growth retardation, crohn's disease (What is crohn's disease?) and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: colorectal cancer (What is colorectal cancer?). Norditropin dosage: 2 Mg, Qd. During the same period patient was treated with REMICADE (300 Mg, Unk) (View Remicade Review and Remicade Label ), VITAMINERAL (1 Tab, Qd) (View Vitamineral Review and Vitamineral Label ), PIKASOL (2000 Mg, Qd) (View Pikasol Review and Pikasol Label ), PENTASA (2500 Mg, Qd) (View Pentasa Review and Pentasa Label ), NIFEREX /00023501/ (100 Mg, Unk) (View Niferex /00023501/ Review and Niferex /00023501/ Label ).

6370420-7 | Aortic Calcification, Supravalvular Aortic Stenosis
Patient was taking Norditropin (View Usage). Patient had the following side effects: aortic calcification, supravalvular aortic stenosis on Sep 18, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 68.56 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: 1.8 Mg, Qd. During the same period patient was treated with LISINOPRIL (10 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), CELLCEPT (200 Mg/ml, Bid) (View Cellcept Review and Cellcept Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), PREDNISONE (7.5 Mg, Qd) (View Prednisone Review and Prednisone Label ), FAMOTIDINE (20 Mg, Bid) (View Famotidine Review and Famotidine Label ), LORATADINE (10 Mg, Qd) (View Loratadine Review and Loratadine Label ), BACTRIM (1 Tab, Bid Mon-wed-fri) (View Bactrim Review and Bactrim Label ).

6370419-0 | Enchondroma
Adverse event was reported on Sep 14, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: .2 Mg, Qd) was diagnosed with hypopituitarism and. Location: GERMANY , weighting 216.3 lb, After Norditropin was administered, patient had the following side effects: enchondroma. During the same period patient was treated with NORPROLAC (75 Ug, Qd) (View Norprolac Review and Norprolac Label ), HYDROCORTISON /00028601/ (15 Mg, Qd) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ), MOXONIDIN (.4 Mg, Qd) (View Moxonidin Review and Moxonidin Label ), ACCUZIDE (20 Mg, Qd) (View Accuzide Review and Accuzide Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ).

6368185-8 | Pituitary Tumour Benign
on Sep 11, 2009 Male patient from UNITED STATES , child 11 years of age, was diagnosed with body height below normal and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: pituitary tumour benign. Norditropin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6340759-X | Ewing's Sarcoma
on Aug 24, 2009 Male patient from ISRAEL , child 11 years of age, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: ewing's sarcoma. Norditropin dosage: .03 Mg/kg, Qd. During the same period patient was treated with DECAPEPTYL /00486501/ (View Decapeptyl /00486501/ Review and Decapeptyl /00486501/ Label ). Patient was hospitalized.

6339946-6 | Osteosarcoma Localised
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: osteosarcoma localised on Aug 24, 2009 from ISRAEL Additional patient health information: Male patient , 17 years of age, was diagnosed with growth hormone deficiency and. Norditropin dosage: .03 Mg/kg, Qd. During the same period patient was treated with ELTROXIN (View Eltroxin Review and Eltroxin Label ). Patient was hospitalized.

6318088-X | Pituitary Tumour Benign
Adverse event was reported on Aug 13, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: 8 Mbq, Qd) was diagnosed with growth hormone deficiency and. Location: GERMANY , weighting 231.5 lb, Patient experienced the following unwanted or unexpected effects: pituitary tumour benign. During the same period patient was treated with HYDROCORTISON /00028601/ (15 Mg, Qd) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ).

6318053-2 | Vasculitis
on Aug 11, 2009 Female patient from BELGIUM , child 12 years of age, weighting 67.90 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: vasculitis (What is vasculitis?). Norditropin dosage: 1.5 Mg, Qd.

6316263-1 | Breast Mass, Condition Aggravated, Diabetic Retinopathy
on Aug 10, 2009 Female patient from UNITED KINGDOM , 41 years of age, was diagnosed with hypopituitarism and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: breast mass, condition aggravated, diabetic retinopathy. Norditropin dosage: .6 Unk, Qd. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6309630-3 | Osteochondrosis
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: osteochondrosis on Aug 06, 2009 from AUSTRIA Additional patient health information: Male patient , weighting 45.19 lb, was diagnosed with small for dates baby and. Norditropin dosage: .03 Mg/kg, Qd. Patient was hospitalized.

6304532-0 | Ependymoma Malignant
Adverse event was reported on Jul 31, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: 1,1mg For 8 Days, 1,2mg For 1 Day Averaging A Dose Of 1.7 Mg A Day To Avoid Wastage) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , weighting 103.0 lb, Patient had the following side effects: ependymoma malignant. During the same period patient was treated with HYDROCORTISONE (12.5 Mg, Qd (5+5+2.5)) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd (50 To 75)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6296218-6 | Colon Cancer, Hepatic Lesion, Metastases To Lymph Nodes
on Jul 24, 2009 Male patient from UNITED KINGDOM , 39 years of age, weighting 140.4 lb, was diagnosed with hypopituitarism and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: colon cancer, hepatic lesion, metastases to lymph nodes. Norditropin dosage: 0.2-0.4mg Qd. During the same period patient was treated with HYDROCORTISONE (20 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TESTOSTERONE (50 Mg, Qd) (View Testosterone Review and Testosterone Label ), DHEA (25 Mg, Qd) (View Dhea Review and Dhea Label ), DDAVP (100 Ug, Qd) (View Ddavp Review and Ddavp Label ), MELATONIN (1 Mg, Unk) (View Melatonin Review and Melatonin Label ), LIOTHYRONINE SODIUM (20 Ug, Qd) (View Liothyronine Sodium Review and Liothyronine Sodium Label ).

6290808-2 | Metastases To Central Nervous System
on Jul 20, 2009 Female patient from SERBIA , weighting 57.32 lb, was diagnosed with hypopituitarism and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to central nervous system. Norditropin dosage: .66 Mg, Qd. Patient was hospitalized.

6290806-9 | Convulsion
Patient was taking Norditropin (View Usage). Patient had the following side effects: convulsion on Jul 20, 2009 from SERBIA Additional patient health information: Male patient , weighting 54.01 lb, was diagnosed with growth hormone deficiency, hypothyroidism and. Norditropin dosage: .8 Mg, Qd. During the same period patient was treated with THYROXIN NATRIUM (75 Ug, Qd) (View Thyroxin-natrium Review and Thyroxin-natrium Label ). Patient was hospitalized.

6286193-2 | Enchondroma
Adverse event was reported on Jul 17, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: .2 Mg, Qd) was diagnosed with hypopituitarism and. Location: GERMANY , weighting 216.3 lb, After Norditropin was administered, patient had the following side effects: enchondroma. During the same period patient was treated with NORPROLAC (75 Ug, Qd) (View Norprolac Review and Norprolac Label ), HYDROCORTISON /00028601/ (15 Mg, Qd) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ), MOXONIDIN (.4 Mg, Qd) (View Moxonidin Review and Moxonidin Label ), ACCUZIDE (20 Mg, Qd) (View Accuzide Review and Accuzide Label ), NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ).

6284631-2 | Lymphocytic Leukaemia
on Jul 20, 2009 Male patient from GERMANY , weighting 33.73 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: lymphocytic leukaemia. Norditropin dosage: .4 Mg, Qd.

6282528-5 | Anogenital Dysplasia
on Jul 16, 2009 Male patient from SWEDEN , 18 years of age, weighting 123.5 lb, was diagnosed with growth retardation, crohn's disease (What is crohn's disease?) and was treated with Norditropin (View Usage). Patient had the following side effects: anogenital dysplasia. Norditropin dosage: . During the same period patient was treated with REMICADE (View Remicade Review and Remicade Label ).

6260086-9 | Gastrointestinal Carcinoma
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: gastrointestinal carcinoma on Jun 30, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, was diagnosed with hypopituitarism and. Norditropin dosage: Unk Mg, Qd (0.2-0.4).

6258316-2 | Ependymoma Malignant
Adverse event was reported on Jun 25, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: 1,1mg For 8 Days, 1,2mg For 1 Day Averaging A Dose Of 1.7 Mg A Day To Avoid Wastage) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , weighting 103.0 lb, Patient experienced the following unwanted or unexpected effects: ependymoma malignant. During the same period patient was treated with HYDROCORTISONE (12.5 Mg, Qd (5+5+2.5)) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd (50 To 75)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6256431-0 | Left Ventricular Hypertrophy, Tricuspid Valve Incompetence
on Jun 25, 2009 Male patient from UNITED STATES , child 8 years of age, weighting 44.09 lb, was diagnosed with noonan syndrome and was treated with Norditropin (View Usage). Patient had the following side effects: left ventricular hypertrophy, tricuspid valve incompetence. Norditropin dosage: 1.4 Mg 6 Days Per Week.

6244769-2 | Panic Disorder
on Jun 17, 2009 Male patient from BRAZIL , 16 years of age, weighting 103.6 lb, was diagnosed with growth retardation and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: panic disorder (What is panic disorder?). Norditropin dosage: .5 Mg, Qd. Patient was hospitalized.

6238926-9 | Alopecia, Amnesia, Asthenia, Autonomic Neuropathy, Balance Disorder, Burning Sensation, Dandruff, Dry Skin, Dysarthria
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, amnesia, asthenia, autonomic neuropathy, balance disorder, burning sensation, dandruff, dry skin, dysarthria on Jun 17, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 140.0 lb, was diagnosed with hormone level abnormal and. Norditropin dosage: 0.35 Mg Daily Sq.

6238586-7 | Aplastic Anaemia, Influenza, Liver Disorder
Adverse event was reported on Jun 12, 2009 by a Female patient taking Norditropin (View Usage) (Dosage: 1.8 Mg, Qd) was diagnosed with turner's syndrome, influenza and. Location: JAPAN , child 11 years of age, weighting 66.14 lb, Patient had the following side effects: aplastic anaemia, influenza, liver disorder. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

6234208-X | Anxiety, Dysphasia, Headache, Visual Impairment
on Jun 10, 2009 Female patient from UNITED KINGDOM , weighting 168.7 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: anxiety (What is anxiety?), dysphasia, headache (What is headache?), visual impairment. Norditropin dosage: .2 Mg, Unk. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (75 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DESMOPRESSIN ACETATE (100 Ug, Prn) (View Desmopressin Acetate Review and Desmopressin Acetate Label ), LOSARTAN POTASSIUM (50 Mg, Qd) (View Losartan Potassium Review and Losartan Potassium Label ), LANSOPRAZOLE (15 Mg, Qd) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6222621-6 | Bacteraemia, Enterobacter Bacteraemia, Gastric Cancer, Jugular Vein Thrombosis
on Jun 02, 2009 Female patient from FRANCE , 74 years of age, weighting 127.9 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, enterobacter bacteraemia, gastric cancer, jugular vein thrombosis. Norditropin dosage: .3 Mg, Unk. During the same period patient was treated with HYDROCORTISONE (20 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), FOSAMAX (140 Mg, Unk) (View Fosamax Review and Fosamax Label ), LEXOMIL (24 Mg, Unk) (View Lexomil Review and Lexomil Label ), MINIRIN (.3 Mg, Unk) (View Minirin Review and Minirin Label ), CACIT D3 (1 Df) (View Cacit D3 Review and Cacit D3 Label ), FORLAX (1 Df) (View Forlax Review and Forlax Label ), LEVOTHYROX (125 Ug, Unk) (View Levothyrox Review and Levothyrox Label ), PANTOPRAZOLE SODIUM (20 Mg, Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ). Patient was hospitalized.

6221214-4 | Hair Follicle Tumour Benign
Patient was taking Norditropin (View Usage). Patient had the following side effects: hair follicle tumour benign on Jun 02, 2009 from SLOVAKIA (Slovak Republic) Additional patient health information: Female patient , child 6 years of age, weighting 34.39 lb, was diagnosed with small for dates baby, growth hormone deficiency and. Norditropin dosage: .5 Mg, Qd.

6220967-9 | Hyperplasia
Adverse event was reported on May 27, 2009 by a Male patient taking Norditropin (View Usage) (Dosage: 2.3 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: UNITED STATES , 16 years of age, weighting 141.0 lb, After Norditropin was administered, patient had the following side effects: hyperplasia.

6216178-3 | Joint Stiffness
on May 28, 2009 Male patient from GERMANY , weighting 34.83 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: joint stiffness. Norditropin dosage: .5 Mg, Qd. Patient was hospitalized.

6215221-5 | Hyperplasia, Melanocytic Naevus
on May 27, 2009 Male patient from UNITED STATES , 16 years of age, weighting 141.0 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: hyperplasia, melanocytic naevus. Norditropin dosage: 2.3 Mg, Qd.

6212940-1 | Hair Follicle Tumour Benign
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: hair follicle tumour benign on May 20, 2009 from SLOVAKIA (Slovak Republic) Additional patient health information: Female patient , child 6 years of age, weighting 34.39 lb, was diagnosed with small for dates baby, growth hormone deficiency and. Norditropin dosage: .5 Mg, Qd.

6212930-9 | Brain Oedema, Central Nervous System Lesion, Condition Aggravated
Adverse event was reported on May 20, 2009 by a Female patient taking Norditropin (View Usage) (Dosage: 0.16 Mg/kg/week) was diagnosed with growth retardation and. Location: , child 7 years of age, Patient experienced the following unwanted or unexpected effects: brain oedema, central nervous system lesion, condition aggravated.

6206642-5 | Condition Aggravated, Dyspnoea, Osteochondroma
on May 22, 2009 Female patient from AUSTRALIA , child 12 years of age, weighting 61.73 lb, was diagnosed with body height below normal and was treated with Norditropin (View Usage). Patient had the following side effects: condition aggravated, dyspnoea, osteochondroma. Norditropin dosage: .75 Mg, Qd. During the same period patient was treated with EPILIM (200 Mg, Qd) (View Epilim Review and Epilim Label ).

6204478-2 | Blood Alkaline Phosphatase Increased
on May 15, 2009 Female patient from JAPAN , child 4 years of age, was diagnosed with hypopituitarism and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: blood alkaline phosphatase increased. Norditropin dosage: 1.7 Mg, Weekly.

6192820-0 | Benign Bone Neoplasm, Fibroma, Hair Follicle Tumour Benign
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: benign bone neoplasm, fibroma, hair follicle tumour benign on May 06, 2009 from SLOVAKIA (Slovak Republic) Additional patient health information: Female patient , child 6 years of age, was diagnosed with small for dates baby, growth hormone deficiency and. Norditropin dosage: .5 Mg, Qd.

6189695-2 | Ovarian Cyst
Adverse event was reported on May 04, 2009 by a Female patient taking Norditropin (View Usage) (Dosage: .6 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: FRANCE , 54 years of age, weighting 143.3 lb, Patient had the following side effects: ovarian cyst (What is ovarian cyst?). During the same period patient was treated with LIPANTHYL (160 Mg, Qd) (View Lipanthyl Review and Lipanthyl Label ), TEGRETOL (600 Mg, Qd) (View Tegretol Review and Tegretol Label ), HYDROCORTISONE (30 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROX (125 Ug, Qd) (View Levothyrox Review and Levothyrox Label ), MINIRIN (.6 Mg, Qd) (View Minirin Review and Minirin Label ). Patient was hospitalized.

6189694-0 | Condition Aggravated, Dyspnoea, Osteochondroma
on May 07, 2009 Female patient from AUSTRALIA , child 12 years of age, weighting 61.73 lb, was diagnosed with body height below normal and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: condition aggravated, dyspnoea, osteochondroma. Norditropin dosage: .75 Mg, Qd. During the same period patient was treated with EPILIM (200 Mg, Qd) (View Epilim Review and Epilim Label ).

6183806-0 | Panic Disorder
on Apr 27, 2009 Male patient from BRAZIL , 16 years of age, weighting 103.6 lb, was diagnosed with growth retardation and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: panic disorder (What is panic disorder?). Norditropin dosage: .5 Mg, Qd. Patient was hospitalized.

6182759-9 | Headache, Nausea
Patient was taking Norditropin (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?) on Apr 29, 2009 from GERMANY Additional patient health information: Male patient , weighting 59.75 lb, was diagnosed with small for dates baby and. Norditropin dosage: 1 Mg, Qd. Patient was hospitalized.